Arcus Biosciences, Inc. · NYSE:RCUS
Goeltz II Robert C. sold 7,763 Arcus Biosciences, Inc. shares (Form 4)
Traded May 11, 2026 · Filed May 12, 2026
On May 11, 2026, Goeltz II Robert C. (Chief Financial Officer) sold 7,763 Arcus Biosciences, Inc. shares at US$25.63 for US$199K under a trading plan, leaving 84,161 shares. Filed May 12, 2026 (Form 4).
- Sold
- 7,763 shares
- Price
- US$25.63
- Value
- US$199K
- Holding after
- 84,161 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 11, 2026 | Common Stock | Sale | 7,763 | US$25.63 | 84,161 | Direct |